BlossomHill Therapeutics, Inc. (BLSM)

NASDAQ: BLSM · Real-Time Price · USD

19.38

+0.39 (2.05%)

Sep 2, 2026, 4:00 PM EDT - Market closed

BlossomHill Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Sep '26 Sep 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Market Capitalization	594	-	-
Market Cap Growth	-	-	-
Enterprise Value	501	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Sep '26 Sep 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Debt / Equity Ratio	0.22	0.18	0.01
Net Debt / Equity Ratio	-0.89	-0.91	-1.00
Net Debt / EBITDA Ratio	1.25	1.80	2.76
Net Debt / FCF Ratio	1.62	2.38	3.16
Quick Ratio	7.17	8.83	14.79
Current Ratio	7.40	8.97	15.38
Return on Equity (ROE)	-	-53.80%	-
Return on Assets (ROA)	-	-29.67%	-
Return on Capital Employed (ROCE)	-58.70%	-43.40%	-36.40%

Yields

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Sep '26 Sep 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Buyback Yield / Dilution	-	-6.47%	-

SEC Filings: 10-K · 10-Q